Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute and Remission Therapy of Ulcerative Colitis With Oral Mesalazine

NCT01363453 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.

NCT NCT01363453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01363453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute and Remission Therapy of Ulcerative Colitis With Oral Mesalazine
Lead sponsor
Ferring Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
October 31, 2007
Completion date
July 31, 2008
Enrollment
500 (actual)
Sites
105

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis